Lifecare ASA

As of June 30, 2026, Lifecare ASA carries a market capitalization of 128.04M, placing it among publicly traded companies globally. Its enterprise value stands at 95.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Lifecare ASA's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Lifecare ASA has 386.25M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 642.28, and the price-to-book ratio stands at 2.31.

These figures are as of June 30, 2026. The EV/Sales ratio of 957.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 95.70M versus a market cap of 128.04M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Lifecare ASA maintains a current ratio of 11.69, meaning it holds 11.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Lifecare ASA posted a negative return on equity (ROE) of -205.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -165.78, reflecting losses generated across the asset base. The company generates approximately 3,809.52 in revenue per employee across its workforce of 26.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Lifecare ASA recorded an income tax benefit of -470,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -118.77M and -117.83M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Lifecare ASA generated 100,000.00 in revenue and converted that into -117.83M in net income, yielding earnings per share of -0.61. EBITDA reached -115.71M, while operating income came in at -114.90M.

As of June 30, 2026, Lifecare ASA holds 36.84M in cash and equivalents against 5.50M in total debt, resulting in a net debt position of -36.84M. Total book value stands at 55.47M, with working capital of 41.27M providing operational flexibility.

Lifecare ASA produced -115.98M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.28M in capital expenditures, free cash flow totaled -120.26M - equivalent to -0.62 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -114,905.00 and net profit margin of -117,827.00 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -187.24: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -98.02, meaning Lifecare ASA raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Lifecare ASA's most recent stock split took place on January 7, 2026 with a 38:109 split ratio.

As of June 30, 2026, Lifecare ASA has an Altman Z-Score of 3.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.